Article
BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1 Dec 2015
Tabouret E, Bequet C, Denicolaï E, Barrié M, Nanni I, Metellus P, Dufour Henri, Chinot O, Figarella-Branger D
Abstract excerpt
BACKGROUND: Pleomorphic xanthoastrocytoma (PXA) is a rare, low-grade glioma that frequently occurs in pediatric patients. OBJECTIVE: To analyze adult patients diagnosed with PXA and to search for pathological and molecular markers of diagnosis and prognosis. METHODS: We retrospectively included patients older than 16 years with PXA who were referred to our institution between October 2003 and September 2013. All...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
